NEW YORK (GenomeWeb News) – Eppendorf today said it has licensed thermal cycler technology to Peqlab Biotechnologie.

Terms of the deal were not disclosed.

The agreement includes US Patent numbers 6,767,512 and 7,074,367. Both the '512 patent, titled "Temperature-regulating block with temperature-regulating devices," and the '367 patent, "Thermostated block with heat-regulating devices," relate to thermostated blocks for laboratory thermostats and comprising wells.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.